Is Curia Missouri, Inc. FDA approved?

Curia Missouri, Inc. holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are Curia Missouri, Inc.'s drugs manufactured?

The FDA register lists Springfield, MO. Registered operations: analytical testing, active ingredient (API) manufacture, particle size reduction.

What drugs does Curia Missouri, Inc. make?

8 products are listed under Curia Missouri, Inc. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Curia Missouri, Inc.

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 1
Active NDC listings: 8
Labeller names: 2
Live patents: 0
Countries: 1
Base: United States

Authorisation

Registered operations

Analytical testing1Active ingredient (API) manufacture1particle size reduction1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
Curia Missouri, Inc.	2460 West Bennett Street, Springfield, Missouri (MO) 65807, United States (USA)	Analytical testing, Active ingredient (API) manufacture, particle size reduction	1941037077120223

Catalogue

Drug listings by form and route

8 active NDC listings: 8 bulk ingredient. By marketing category: BULK INGREDIENT 5, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 3.

Dosage form	NDCs
powder	8

Route	NDCs

Labeller name on the listing	NDCs
curia missouri, inc.	6
curia missouri inc.	2

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
-	CHOLINE FENOFIBRATE	powder	17180-0201BULK INGREDIENT
-	DEXMETHYLPHENIDATE HYDROCHLORIDE	powder	17180-1725BULK INGREDIENT
-	Gamma Hydroxybutyric Acid	powder	17180-2010BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	LACOSAMIDE	powder	17180-2746BULK INGREDIENT
-	METHYLPHENIDATE HYDROCHLORIDE	powder	17180-1724BULK INGREDIENT
-	Regadenoson Anhydrous	powder	17180-0203BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Serdexmethylphenidate Chloride	powder	17180-1729BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Tapentadol Hydrochloride	powder	17180-9780BULK INGREDIENT

Compare

Comparable companies in United States

Rising Pharma Holdings, Inc.1 site · 532 NDC
ANI Pharmaceuticals, Inc.1 site · 299 NDC
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 site · 273 NDC
Lannett Company, LLC1 site · 190 NDC
OHM PHARMA INC.1 site · 155 NDC
CHATTEM, INC.1 site · 153 NDC
PAI Holdings, LLC1 site · 146 NDC
Allegiant Health1 site · 113 NDC
Healthcare Sales and Service, LLC1 site · 105 NDC
Civica, Inc. dba CivicaRx1 site · 103 NDC

Enquiry

Common questions

Is Curia Missouri, Inc. FDA approved?: Curia Missouri, Inc. holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Curia Missouri, Inc.'s drugs manufactured?: The FDA register lists Springfield, MO. Registered operations: analytical testing, active ingredient (API) manufacture, particle size reduction.
What drugs does Curia Missouri, Inc. make?: 8 products are listed under Curia Missouri, Inc. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.